Dr. Agarwals Health Care Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹-4(-1.00%)
Premium (ELP)
Dr. Agarwals Health Care Limited's successfully transitioned to public market status with its listing on NSE, BSE on Feb 04, 2025. The IPO mobilized 7,53,04,970 Shares in cumulative capital, including 74,62,686 Shares for corporate expansion and ₹2727.26 Cr for shareholder liquidity management.
The public offering was conducted within the price parameters of ₹382 to ₹402, with minimum investment lots of 35 shares. subscription activity between Jan 29, 2025 and Jan 31, 2025 demonstrated market reception to the company's valuation and growth narrative.
The allotment process concluded on Feb 01, 2025, finalizing share distribution to successful bidders. The listing represents a transformational event, providing the company with enhanced market visibility, regulatory compliance framework, and access to diversified investor capital.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Dr. Agarwal’s Health Care Limited, founded on April 19, 2010, is a leading eye care provider in India. Based in Chennai, Tamil Nadu, the company runs one of the largest networks of eye hospitals both in India and internationally. They specialize in advanced eye care services like cataract surgeries, retinal treatments, refractive surgeries, corneal transplants, glaucoma management, and pediatric eye care. Known for using the latest technologies and innovative surgical methods, the company is trusted by patients for its high-quality care. Dr. Agarwal’s also offers customized treatments for complex eye conditions and has a team of highly skilled ophthalmologists and staff to ensure the best results. They are committed to constantly improving by investing in new medical technologies and training programs. As of March 31, 2024, the company has expanded globally and employs over 1,000 professionals, including doctors, researchers, and administrative staff, all working towards making top-notch eye care accessible and affordable for everyone.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Strong Brand Reputation: Known as a top provider of eye care, the company has built a trusted brand among patients.
- Cutting-Edge Technology: Uses the latest technologies to ensure precise and effective treatments.
- Global Reach: Has a large network of hospitals both in India and around the world.
- Tough Competition: The healthcare sector is highly competitive, with pressure to keep prices competitive.
- Regulatory Requirements: The company must follow strict medical and financial regulations.
- Operational Challenges: Relies on skilled staff and faces the risk of equipment becoming outdated.
- Dr. Amar Agarwal,
- Dr. Athiya Agarwal
- Dr Adil Agarwal
- Dr. Anosh Agarwal
- Dr Ashvin Agarwal
- Dr. Ashar Agarwal
- Dr. Amar Agarwal Family Trust
- Dr Adil Agarwal Family Trust
- Dr. Anosh Agarwal Family Trust
- Dr Ashvin Agarwal Family Trust
- Dr. Ashar Agarwal Family Trust
- Dr Agarwal’s Eye Institute
- Dr Agarwal's Eye Institute Private Limited
Dr. Agarwals Health Care Limited
Kfin Technologies Limited